SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...
Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and treatment, ...
Dexcom has kick-started a new, multiyear program that spotlights college athletes with diabetes to inspire others living with the disease to continue playing sports. Maker of continuous glucose ...
Zacks Investment Research on MSN
DXCM secures Health Canada authorization for Dexcom G7 15 day CGM
DexCom DXCM recently announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System has received ...
The "direct-to-watch" feature eliminates the need to keep your phone near for readings. Dexcom is looking into other smartwatches too, the company's COO says. Jessica was a writer on the Wellness team ...
Add Yahoo as a preferred source to see more of our stories on Google. Dexcom received FDA clearance for a 15-day version of its G7 continuous glucose monitor. Research shared by Dexcom at the American ...
Dexcom G6 users can see glucose levels and trends at a glance, even while working out People with diabetes can now view Dexcom CGM data on their Garmin smartwatch or cycling computer (Photo: Business ...
Medical Device Network on MSN
Health Canada authorises Dexcom G7 15 day CGM
The device demonstrates a MARD of 8% and includes a 12-hour grace period and mobile app compatibility.
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results